Conjunctivitis in the practice of a primary care physician – friend or foe?
DOI:
https://doi.org/10.12775/JEHS.2025.82.60306Keywords
conjunctivitis, red eye, primary care, general practiceAbstract
Introduction and purpose: Conjunctivitis is one of the most common ocular conditions that primary care physicians encounter. As a very frequent and usually benign disease, most cases do not require a referral to a specialist and are managed by the general practitioners. Apart from being a stand-alone condition, conjunctivitis may also be a part of clinical presentations of some systemic diseases – both infectious and inflammatory. By being well-recognizable by GPs it can serve as an indicator, pointing them towards possible diagnoses and indicating the need for further testing. On the other hand, numerous ocular conditions share similar symptoms with conjunctivitis, some of which may be vision-threatening. It is therefore crucial not to misdiagnose them as simple or benign conjunctivitis, because overlooking and neglecting these diseases may have serious health consequences, including vision loss. The aim of this article is to review the condition, drawing attention to these two aspects of conjunctivitis as particularly important in the work of a primary care physician – as both a possible indicator for other, systemic conditions, and a diagnostic challenge due to a symptom overlap with many more severe ophthalmic diseases.
Materials and methods: A review of literature was carried out using online platforms Google Scholar and PubMed. Articles were searched by entering keywords: conjunctivitis, red eye, primary care, general practice.
Description of current knowledge: Conjunctivitis is a common condition often seen by general practitioners. It has three main types: viral, bacterial and allergic. It can manifest as a symptom of systemic diseases and shares symptoms with other eye conditions. Conjunctivitis is generally self-limiting and doesn't require treatment. However, evident bacterial cases may benefit from antiseptic or antibiotic therapy to prevent complications and reduce transmission.
References
1. Hashmi MF, Gurnani B, Benson S. Conjunctivitis. In: StatPearls. StatPearls Publishing; 2025. Accessed March 30, 2025. http://www.ncbi.nlm.nih.gov/books/NBK541034/
2. Gin C, Crock C, Wells K. Conjunctivitis: A review. Aust J Gen Pract. 2024;53(11):847-852. doi:10.31128/AJGP-09-23-6960
3. Morrow GL, Abbott RL. Conjunctivitis. afp. 1998;57(4):735-746.
4. Cronau H, Kankanala RR, Mauger T. Diagnosis and management of red eye in primary care. Am Fam Physician. 2010;81(2):137-144.
5. Friedlaender MH. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clinical Therapeutics. 1995;17(5):800-810. doi:10.1016/0149-2918(95)80058-1
6. Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmologica. 2008;86(1):5-17. doi:10.1111/j.1600-0420.2007.01006.x
7. Dupuis P, Prokopich CL, Hynes A, Kim H. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol. 2020;16:5. doi:10.1186/s13223-020-0403-9
8. Villegas BV, Benitez-Del-Castillo JM. Current Knowledge in Allergic Conjunctivitis. Turk J Ophthalmol. 2021;51(1):45-54. doi:10.4274/tjo.galenos.2020.11456
9. Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi:10.1016/j.idcr.2020.e00774
10. Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2501-2507. doi:10.1007/s00417-020-04916-0
11. Güemes‐Villahoz N, Burgos‐Blasco B, Arribi‐Vilela A, et al. Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19? J Med Virol. 2021;93(1):383-388. doi:10.1002/jmv.26219
12. Loffredo L, Oliva A, Paraninfi A, et al. An observed association between conjunctivitis and severity of COVID-19. Journal of Infection. 2021;83(3):381-412. doi:10.1016/j.jinf.2021.06.006
13. Branche AR, Falsey AR. Parainfluenza Virus Infection. Semin Respir Crit Care Med. 2016;37(4):538-554. doi:10.1055/s-0036-1584798
14. Schoini P, Karampitsakos T, Avdikou M, Athanasopoulou A, Tsoukalas G, Tzouvelekis A. Measles pneumonitis. Adv Respir Med. 2019;87(1):63-67. doi:10.5603/ARM.a2019.0010
15. Wang MF, Wang L, Li LF. Gonococcal conjunctivitis after incomplete treatment of gonococcal urethritis. Infect Drug Resist. 2019;12:1381-1384. doi:10.2147/IDR.S199163
16. Cheeti A, Chakraborty RK, Ramphul K. Reactive Arthritis. In: StatPearls. StatPearls Publishing; 2025. Accessed March 26, 2025. http://www.ncbi.nlm.nih.gov/books/NBK499831/
17. Aitken-Saavedra J, Maturana-Ramirez A, Fernández Moraga J, Doro Dias V, Galdino-Santos L, Pineda Flores D. Reactive arthritis: images. Dermatology Online Journal. 2021;27(7). doi:10.5070/D327754373
18. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484
19. Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki Disease and COVID-19. Mediterr J Rheumatol. 2020;31(Suppl 2):268-274. doi:10.31138/mjr.31.3.268
20. Junek ML, Zhao L, Garner S, et al. Ocular manifestations of ANCA-associated vasculitis. Rheumatology (Oxford). 2023;62(7):2517-2524. doi:10.1093/rheumatology/keac663
21. Nejabat M, Mahmoudi Nezhad GS, Shenavandeh S, Ashraf MJ, Jalalpour MH. Conjunctivitis as a manifestation of Wegener’s Granulomatosis. J Curr Ophthalmol. 2018;30(3):268-272. doi:10.1016/j.joco.2017.11.003
22. Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016;30(2):117-121. doi:10.1016/j.sjopt.2016.02.001
23. Judge AJ, Najafi K, Lee DA, Miller KM. Corneal Endothelial Toxicity of Topical Anesthesia. Ophthalmology. 1997;104(9):1373-1379. doi:10.1016/S0161-6420(97)30128-6
24. Prajakta V B, Silva M, Nachiket P, Silva M. ASSESSING KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING CONJUNCTIVITIS AMONG PRIMARY HEALTH CARE PROFESSIONALS. HARYANA JOURNAL OF OPHTHALMOLOGY. 2024;XVI(1):60.
25. Chan VF, Yong ,Ai Chee, Azuara-Blanco ,Augusto, et al. A Systematic Review of Clinical Practice Guidelines for Infectious and Non-infectious Conjunctivitis. Ophthalmic Epidemiology. 2022;29(5):473-482. doi:10.1080/09286586.2021.1971262
26. Filleul L, Pagès F, Wan GNC, Brottet E, Vilain P. Costs of Conjunctivitis Outbreak, Réunion Island, France - Volume 24, Number 1—January 2018 - Emerging Infectious Diseases journal - CDC. doi:10.3201/eid2401.170916
27. Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C. The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells. 2021;10(4):796. doi:10.3390/cells10040796
28. Chen YY, Liu SH, Nurmatov U, van Schayck OC, Kuo IC. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2023;3(3):CD001211. doi:10.1002/14651858.CD001211.pub4
29. Granet DB, Dorfman M, Stroman D, Cockrum P. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus. 2008;45(6):340-349. doi:10.3928/01913913-20081101-07
30. Jefferis J, Perera R, Everitt H, et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract. 2011;61(590):e542-548. doi:10.3399/bjgp11X593811
31. Prost ME. Leczenie zapaleń spojówek w XXI wieku. Ophthatherapy. 2024;11(1):47-53. doi:10.24292/01.OT.300324.1
32. Manente R, Santella B, Pagliano P, et al. Prevalence and Antimicrobial Resistance of Causative Agents to Ocular Infections. Antibiotics (Basel). 2022;11(4):463. doi:10.3390/antibiotics11040463
33. Bispo PJM, Sahm DF, Asbell PA. A Systematic Review of Multi-decade Antibiotic Resistance Data for Ocular Bacterial Pathogens in the United States. Ophthalmol Ther. 2022;11(2):503-520. doi:10.1007/s40123-021-00449-9
34. Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol. 2004;137(3):453-458. doi:10.1016/j.ajo.2003.10.026
35. Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic Prescription Fills for Acute Conjunctivitis among Enrollees in a Large United States Managed Care Network. Ophthalmology. 2017;124(8):1099-1107. doi:10.1016/j.ophtha.2017.04.034
36. Mahoney MJ, Bekibele R, Notermann SL, Reuter TG, Borman-Shoap EC. Pediatric Conjunctivitis: A Review of Clinical Manifestations, Diagnosis, and Management. Children (Basel). 2023;10(5):808. doi:10.3390/children10050808
37. Honkila M, Koskela U, Kontiokari T, et al. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(10):e2234459. doi:10.1001/jamanetworkopen.2022.34459
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jan Wilk, Jakub Jarmołowicz, Karolina Krochmal, Paulina Krzeszowska, Aleksandra Kujawa, Radosław Kuźma, Karolina Marrodán-Wojtczak, Adrianna Samoraj, Kacper Stępniak, Jakub Zajączkowski

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 265
Number of citations: 0